Cargando…

Atypical hemolytic uremic syndrome: Unique clinical presentation linked to rare CFHR5 mutation

Detalles Bibliográficos
Autores principales:	Menotti, Sofia, Donini, Martino, Pessolano, Giuseppina, Tiro, Livia, Cantini, Maurizio, Croce, Jacopo, Morandi, Matteo, Mazzi, Filippo, Donadello, Katia, Olivieri, Oliviero, Dima, Francesco, De Marchi, Sergio, Gambaro, Giovanni, Polati, Enrico, De Franceschi, Lucia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175842/ https://www.ncbi.nlm.nih.gov/pubmed/35845199 http://dx.doi.org/10.1002/jha2.288

Ejemplares similares

Deletion of Complement Factor H–Related Genes CFHR1 and CFHR3 Is Associated with Atypical Hemolytic Uremic Syndrome
por: Zipfel, Peter F, et al.
Publicado: (2007)

CFH-CFHR1 hybrid genes in two cases of atypical hemolytic uremic syndrome
por: Sugawara, Yuka, et al.
Publicado: (2023)

Association among Complement Factor H Autoantibodies, Deletions of CFHR, and the Risk of Atypical Hemolytic Uremic Syndrome
por: Jiang, Hong, et al.
Publicado: (2016)

CFH and CFHR structural variants in atypical Hemolytic Uremic Syndrome: Prevalence, genomic characterization and impact on outcome
por: Piras, Rossella, et al.
Publicado: (2023)

Atypical haemolytic uremic syndrome with refractory multiorgan involvement and heterozygous CFHR1/CFHR3 gene deletion
por: Diep, Jason, et al.
Publicado: (2023)

Analysis of Linear Antibody Epitopes on Factor H and CFHR1 Using Sera of Patients with Autoimmune Atypical Hemolytic Uremic Syndrome
por: Trojnár, Eszter, et al.
Publicado: (2017)

High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele CFHR3*B
por: Pouw, Richard B., et al.
Publicado: (2018)

Corrigendum: High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele CFHR3(*)B
por: Pouw, Richard B., et al.
Publicado: (2020)

Glucose-6-phosphate dehydrogenase deficiency associated hemolysis in COVID-19 patients treated with hydroxychloroquine/chloroquine: New case reports coming out
por: De Franceschi, Lucia, et al.
Publicado: (2020)

Acute hemolysis by hydroxycloroquine was observed in G6PD-deficient patient with severe COVD-19 related lung injury
por: De Franceschi, Lucia, et al.
Publicado: (2020)

Hemolytic uremic syndrome.
por: Beers, M, et al.
Publicado: (1995)

Atypical hemolytic uremic syndrome
por: Loirat, Chantal, et al.
Publicado: (2011)

Recurrent hemolytic uremic syndrome
por: Lakshminarayana, G., et al.
Publicado: (2008)

Atypical Hemolytic Uremic Syndrome
por: Kavanagh, David, et al.
Publicado: (2013)

Management of hemolytic uremic syndrome
por: Kavanagh, David, et al.
Publicado: (2014)

Postinfectious Hemolytic Uremic Syndrome
por: Bitzan, Martin, et al.
Publicado: (2016)

Hemolytic Uremic Syndrome in Children
por: Gülhan, Bora, et al.
Publicado: (2021)

The genetics of atypical hemolytic uremic syndrome
por: Feitz, Wouter J. C., et al.
Publicado: (2018)

Determining the Population Frequency of the CFHR3/CFHR1 Deletion at 1q32
por: Holmes, Lucy V., et al.
Publicado: (2013)

What has vaccination against COVID-19 in CKD patients taught us?
por: Rossi, Mattia, et al.
Publicado: (2023)

Drug-induced hemolytic uremic syndrome
por: Cavoli, G. Li, et al.
Publicado: (2011)

Hemolytic–Uremic Syndrome in a Grandmother
por: Crawford, Lane C., et al.
Publicado: (2010)

Hemolytic-Uremic Syndrome in Asir Region
por: Al Harbi, Naffaa N., et al.
Publicado: (1996)

Gemcitabine induced hemolytic uremic syndrome
por: Sadjadi, Seyed-Ali, et al.
Publicado: (2012)

Management of hemolytic-uremic syndrome in children
por: Grisaru, Silviu
Publicado: (2014)

Pathogenesis of Atypical Hemolytic Uremic Syndrome
por: Yoshida, Yoko, et al.
Publicado: (2019)

Associations of CFH Polymorphisms and CFHR1-CFHR3 Deletion with Blood Pressure and Hypertension in Chinese Population
por: Gan, Wei, et al.
Publicado: (2012)

Thrombotic Microangiopathic Hemolytic Anemia without Evidence of Hemolytic Uremic Syndrome
por: Özsoylu, Şinasi
Publicado: (2016)

COVID-19 vaccination and Atypical hemolytic uremic syndrome
por: Bouwmeester, Romy N., et al.
Publicado: (2022)

Novel CFHR2-CFHR1 Hybrid in C3 Glomerulopathy Identified by Genomic Structural Variation Analysis
por: Sugawara, Yuka, et al.
Publicado: (2019)

Shiga toxin-associated hemolytic uremic syndrome complicated by intestinal perforation in a child with typical hemolytic uremic syndrome
por: Chang, Hye Jin, et al.
Publicado: (2014)

Case Report: Microangiopathic Hemolytic Anemia With Normal ADAMTS13 Activity
por: Osti, Nicola, et al.
Publicado: (2021)

New Therapeutic Options for the Treatment of Sickle Cell Disease
por: Matte, Alessandro, et al.
Publicado: (2019)

Complement factor H and the hemolytic uremic syndrome
por: Atkinson, John P., et al.
Publicado: (2007)

Clostridium septicum infection and hemolytic uremic syndrome.
por: Barnham, M, et al.
Publicado: (1998)

Virulence Factors for Hemolytic Uremic Syndrome, Denmark
por: Ethelberg, Steen, et al.
Publicado: (2004)

Hemolytic Uremic Syndrome Incidence in New York
por: Chang, Hwa-Gan H., et al.
Publicado: (2004)

Hemolytic-Uremic Syndrome in Uberlândia, MG, Brazil
por: Bonetti, V., et al.
Publicado: (2011)

Pregnancy-Associated Atypical Hemolytic-Uremic Syndrome
por: Saad, Antonio F., et al.
Publicado: (2016)

Hemolytic Uremic Syndrome: Toxins, Vessels, and Inflammation
por: Cheung, Victoria, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_h72pm7nofjuej678innnsvf5ml